Francois Martelet

Francois Martelet is a highly accomplished professional with a diverse educational background and extensive experience in the pharmaceutical and biopharmaceutical industries.

Having studied at prestigious institutions such as Insead, Harvard Business School, and the Université De Bourgogne, Francois has a strong academic foundation in Business Administration, Leadership, Finance, Law, Forensics, and Medicine.

Throughout his career, Francois Martelet has held key leadership positions in various organizations. He currently serves as the Chief Executive Officer at Oasmia Pharmaceutical Ab.

Prior to his current role, Francois held the position of Non-Executive Director at Novigenix Sa and served as the Chief Executive Officer at Netscientific Group Plc.

His previous roles include Senior positions at Stallergenes Greer, European Biopharmaceutical Enterprises (Ebe), Topotarget A/S, Avax-Technologies, Merck, and Novartis, where he contributed significantly to the growth and success of these companies.

With a wealth of experience ranging from executive leadership to oncology and global franchise management, Francois Martelet has established himself as a prominent figure in the pharmaceutical industry.